Defiance Daily Target 2X Long MRNA ETF (MRNX) price, chart and fund profile
Price chart
Fund profile
MRNX seeks daily investment results, before fees and expenses, of two times (200%) the daily percentage change in the share price of Moderna, Inc. (NASDAQ: MRNA).
- Issuer
- Tidal Investments LLC
- Industry
- —
- Inception
- Feb 3, 2026
- Assets under management
- $53.6M
- Expense ratio
- 1.31%
- Net asset value
- $82.55
- NAV as of
- Aug 27, 2026
- Leverage
- 2×
- Fund page
- www.defianceetfs.com↗
Frequently asked questions
What is Defiance Daily Target 2X Long MRNA ETF (MRNX)?
MRNX seeks daily investment results, before fees and expenses, of two times (200%) the daily percentage change in the share price of Moderna, Inc. (NASDAQ: MRNA).
What is MRNX's expense ratio?
Defiance Daily Target 2X Long MRNA ETF charges an annual expense ratio of 1.31%. The fund is issued by Tidal Investments LLC.
How large is MRNX?
Defiance Daily Target 2X Long MRNA ETF manages $53.6M in assets and has traded since Feb 3, 2026.
How do I buy shares of Defiance Daily Target 2X Long MRNA ETF (MRNX)?
MRNX trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web dashboard at portal.lighthorse.io, the trading API, or an AI agent connected over MCP. The trade panel on this page places the order once you are signed in.
Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.